TADALAFIL GENERICHEALTH, TADALAFIL LAPL, TADALAFIL GH (Lupin Australia Pty Limited)
Product name
TADALAFIL GENERICHEALTH, TADALAFIL LAPL, TADALAFIL GH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
171 working days (255)
Active ingredients
Tadalafil
Registration type
New generic medicine
Indication
TADALAFIL GENERICHEALTH, TADALAFIL LAPL, TADALAFIL GH (tablets) is indicated for the treatment of:
- erectile dysfunction (ED) in adult males; and
- moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males.